A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma

This study has been withdrawn prior to recruitment.

( Sponsor withdrew support )

Study NCT00668499 Information provided by USC/Norris Comprehensive Cancer Center

First Received: April 25, 2008 Last Updated: January 8, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been withdrawn prior to recruitment.
Estimated Study Completion Date:	April 2011
Estimated Primary Completion Date:	April 2011 (Final data collection date for primary outcome measure)